DOI: http://dx.doi.org/10.18203/2349-3933.ijam20205051

Clinical efficacy of ayurveda treatment modalities in the management of garbhashosh (intrauterine growth restriction): a systematic review

Sarika T. Shinde

Abstract


Concept of fetal well-being has gained importance in conventional science in recent era, but this concept of ‘supraja janana’ was a prime concern of Ayurveda since old era. Apart from prematurity, intrauterine growth restriction (IUGR) is a major public health problem in most of the developing countries. While going through ayurved classics it is revealed that garbhashosh is one of the disease, which is comparable to intrauterine growth restriction in modern medicine. In Ayurveda various drugs and preparations have been described for treatment of garbhashosh. These drugs are comparatively safe without any unwanted side effects. Aim of this work was to review and meta-analyze the effictiveness of various ayurvedic treatment modalities for garbhashosh with respect to (w.r.t.) IUGR. An attempt to expand the concept of IUGR according to Ayurveda and to yield a flourishing result to this world-wide problem through Ayurveda, this topic has been selected for the study. Going through pathology and main clinical signs and symptoms, garbhashosh can be correlated with IUGR. It is observed that, total 5 clinical studies and 1 case study have been reported on management of IUGR by using classical formulations of Ayurveda. The results and observations obtained through demographical data, effect of therapy observed on the ultrasound parameters as well clinical parameters of garbhashosh w.r.t. IUGR were statistically significant. Results were obtained in favour of most of the ayurvedic formulations. Through this review it can be stated that bruhaniya gana sidha kshirbasti and kshirpan, shatavari kshirbasti, shatavaryadi kshirbasti, yashtimadhu vidari siddha kshirbasti, shatavari ashwagandha phalaghruta kshirbasti, can be given to a pregnant women with IUGR after completion of 28th weeks of gestation, without any complication either in mother or in child. It is cost effective as compared to modern drug.


Keywords


Garbhshosh, Garbhakshaya, Intrauterine growth restriction, Kshirbasti, Kshirpan

Full Text:

PDF

References


Sushruta samhita (Hindi). Motilal Banarasidas, Delhi, 5th Edition. Sharirsthan adhyaya no. 10/62. 1975.

Sushruta samhita (Hindi). Motilal Banarasidas, Delhi. 5th Edition, sutrasthan adhyaya no 15/22. 1975.

Kashyap samhita Vridhajivaka Vidyotini, Hindi Commentary by Bhaishjyaratnamani DS. Chauckhamba Prakashan, Varanasi. 8th Edition. khilasthan adhyaya no 22 bhojankalpadhyaya. 2002.

Charak samhita with Vidyotani Vyakhya (Hindi). Chaukhamba Bharati Academy, Varanasi. 19th Edition. Sharirsthan adhyaya no 8/20. 1993.

Ashtang Sangrah Ashtanga Sangrahah with Sarvanga Sundari Vyakhya of Pt. Lalchandra Shastry Vaidya (Hindi). Baidyanath Ayurveda Bhavan Private Ltd. 1st Edition. Sharirstan adhyaya no 2/37. 1989.

Ashtang Hruday Ashtanga Hridayam with Sarvanga Sundari Vyakhya (Hindi). Motilal Banarasidas Publishers Pvt. Ltd., Delhi. 1st Edition. Sharirstan adhyaya no 1/43-47. 1990.

Dalhantika on Charaka Samhita with Vidyotani Vyakhya (Hindi). Chaukhamba Bharati Academy, Varanasi. 19th Edition, 1993.

Charak samhita with Vidyotani Vyakhya (Hindi). Chaukhamba Bharati Academy, Varanasi. 19th Edition. Sharirsthan adhyaya no 2/151993.

Dewaikar SJ, Shinde S. Controlled Clinical Evaluation of Bruhaniya Ganasiddha Kshirpan and Kshirbasti in the Management of Garbhashosh with Special Reference to IUGR. J Dent Med Sci. 2014;13(8):30-361.

Kour J, Donga SB. Role Of Shatavari Ksheerabasti In The Management Of Oligohydramnios - A Case Study. Int Ayur Med J. 2016;4(10).

Suprabha K. Role of Shatavaryadi Ksheerapaka Basti in Garbha Kshaya - Case Series. 2017;2(5).

Singh S. Effect of Yashtimadhu, Vidari Siddha Ksheerabasti On Pregnancy. 2017;4(3).

Anu MS, Kunjibettu S, Archana S, Dei L. Management of premature contractions with Shatavaryadi Ksheerapaka Basti-A Case Report. 2017;38(3-4):148-52.

Jadhav AS. Efficacy of Sharavari and Ashwagandha ksheerbasti in oligohydroamnios: case study. Int J Res Ind Med. 2017;1(4).

Deshmukh S, Mundada PS, Ram TS, Gundeti MS. Protocol for Systematic Review and Meta-analysis of Ayurvedic Interventions for Essential Hypertension. J Res Ayur Sci. 2019;3(1):17-21.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;21;6(7):1000100.